Loading clinical trials...
Loading clinical trials...
This is a prospective biomarker study that aims at demonstrating the impact of liquid biopsy to deliver better treatment for cancer patients with metastatic disease managed in the community setting
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
NCT05525858 · Solid Tumor, Advanced Solid Tumor, and more
NCT05076760 · Solid Tumor, Advanced Cancer, and more
NCT06678659 · Unresectable, Locally Advanced, and more
NCT06085716 · Metastatic Cancers, Fatigue
NCT07197671 · Metastatic Cancer
CH de la Côte Basque
Bayonne
CH de Bligny
Bligny
Polyclinique Bordeaux Nord Aquitaine
Bordeaux
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions